26,927 findings
- Energy balanceGood
Weight loss of 7-10% is required to improve histological disease activity and features of MASLD, while 3-5% weight loss stabilizes or improves fibrosis in normal-weight patients.
If you have MASLD, aim for a 7-10% reduction in body weight if you are overweight or obese, or 3-5% if you are normal weight. This is achieved by creating a daily calorie deficit of 500-1,000 kcal. Even if you cannot reach the higher target, losing just 5% of your body weight is highly likely to stabilize or improve liver fibrosis.
Qualifies 2024 - Macro partitioningGood
Adherence to a Mediterranean diet improves liver steatosis and metabolic parameters, and is the only diet pattern recommended as potential therapy for MASLD by major scientific societies.
Adopt a Mediterranean diet pattern: fill half your plate with vegetables, use olive oil as your primary fat, eat whole grains, and include fish and legumes regularly. Limit red meat and sweets. This pattern is the only one officially recommended for treating MASLD because it improves liver fat, blood sugar, and cholesterol simultaneously.
Supports 2024 - Energy balanceGood
Moderate-to-vigorous physical activity (150-200 minutes/week) reduces intrahepatic lipid and improves MASLD outcomes, with vigorous exercise offering full benefits for steatohepatitis and fibrosis.
Aim for 150-200 minutes of moderate-to-vigorous physical activity per week, spread over 3-5 sessions. This can include brisk walking, cycling, or running. If you have joint issues, resistance training is also effective. Exercise reduces liver fat even if you don't lose weight, so start moving regardless of scale changes.
Supports 2024 - Micronutrients & recoveryGood
Excessive fructose consumption (e.g., >7 sugary drinks/week) is associated with hepatic fibrosis independent of calorie intake, and fructose-restricted diets decrease liver triglycerides.
Avoid sugary drinks and limit free sugars. High fructose intake causes liver fibrosis even if you don't gain weight. Switching to a fructose-restricted diet for just 6-8 weeks can reduce liver fat.
Refutes 2024 - AdherenceGood
Initiating moderate-to-vigorous exercise after a new diagnosis of type 2 diabetes significantly reduces the risk of myocardial infarction, stroke, and all-cause mortality compared to remaining sedentary.
If you were just diagnosed with type 2 diabetes, start moving now. You do not need to be an athlete. Aim for at least 150 minutes of moderate activity (like brisk walking) per week. This single change can lower your risk of heart attack, stroke, and death by about 15-16% compared to staying sedentary.
Supports 2022 - AdherenceGood
The combination of smoking cessation and exercise initiation after a new diabetes diagnosis yields the greatest reduction in cardiovascular disease risk (46% reduction) and all-cause mortality (22% reduction) compared to continuing both bad habits.
For the best heart and life protection after a diabetes diagnosis, quit smoking and start exercising. Doing both together cuts your risk of heart disease by nearly half and death by over 20% compared to staying a smoker and sedentary. If you can only do one, start with exercise, but quitting smoking is also critical.
Supports 2022 - Macro partitioningGood
Older adults require protein intakes 50–100% higher than the standard RDA (~0.8 g/kg/day) to overcome anabolic resistance and preserve muscle mass.
If you are older, the standard protein recommendation is likely too low to stop muscle loss. Aim for roughly 1.2 to 1.6 grams of protein per kilogram of body weight every day, and combine this with regular resistance and aerobic exercise to effectively preserve your muscle mass.
Supports 2024 - AdherenceGood
Resistance exercise is the primary mechanical stimulus to prevent the decline in Type 2 muscle fiber cross-sectional area in older adults.
Engage in regular resistance training to maintain the size and function of your fast-twitch muscle fibers. This mechanical stimulus is crucial for keeping your muscles strong and functional as you age.
Supports 2024 - AdherenceGood
Short-term periods of physical inactivity (disuse) accelerate muscle atrophy and strength loss in older adults, mimicking years of natural aging.
Avoid prolonged periods of inactivity, such as bedrest or hospitalization, as they cause rapid muscle loss in older adults that is difficult to reverse. Maintain daily movement even during minor illnesses or injuries.
Supports 2024 - MixedGood
Drop set training produces similar muscular strength and hypertrophy adaptations compared to traditional training, while offering greater time efficiency.
If you are short on time, drop sets are a valid alternative to traditional sets for building muscle and strength. You do not need to sacrifice results for speed. Perform exercises to failure, then immediately reduce the weight by 10-20% and continue to failure. This can reduce your workout time by 30-70% while producing similar adaptations to traditional training. Note that current evidence is limited to young men.
Qualifies 2022 - MixedGood
Low-load resistance training (25-35 reps) to failure produces significantly greater volume load accumulation over 8 weeks compared to high-load resistance training (8-12 reps) to failure in well-trained men.
If you want to maximize the total amount of work (volume load) you do in a session, use lighter weights and perform more repetitions (25-35) until you can't do another rep with good form. This approach accumulates significantly more total weight moved over 8 weeks than using heavier weights for fewer reps (8-12), provided you train to failure in both cases.
Supports 2016 - HormonalGood
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) induce significant weight loss (≥10%) and reduce major adverse cardiovascular events (MACE) in patients with obesity, outperforming conventional anti-obesity drugs and lifestyle modification alone.
If you have obesity and are at risk for heart disease, GLP-1 receptor agonists like semaglutide or liraglutide are currently the most effective pharmacological options for achieving significant weight loss (often >10%) and reducing cardiovascular risk. Unlike older weight-loss drugs or lifestyle changes alone, these medications address the hormonal drivers of weight regain and offer specific heart benefits. However, they require long-term use to maintain results, and treatment should be discussed with a healthcare provider to weigh benefits against costs and side effects.
Supports 2022 - Energy balanceGood
Increases in diet quality and physical activity are the most significant determinants of weight loss during periods of lifestyle disruption.
To lose weight during stressful times, focus on improving what you eat (diet quality) and moving more (physical activity). These are the two most powerful tools for managing weight when your routine is disrupted.
Supports 2021 - HormonalGood
Tirzepatide, a GIP/GLP-1 receptor agonist, achieves unprecedented reductions in HbA1c and clinically significant weight loss in Type 2 Diabetes patients, with a substantial proportion achieving normoglycemia without hypoglycemia.
Tirzepatide is a once-weekly injection that significantly lowers blood sugar and promotes substantial weight loss in people with Type 2 Diabetes, often without causing low blood sugar. It is designed to be started at a low dose and gradually increased to minimize side effects like nausea. This treatment challenges the old view that effective diabetes management requires insulin or causes weight gain.
Supports 2023 - HormonalGood
Multi-receptor incretin drugs (Tirzepatide, Retatrutide, Mazdutide, Survodutide) produce substantial weight loss (>8kg) and glycemic control (HbA1c reduction >1%) in adults with overweight/obesity, with non-diabetic populations showing more pronounced effects than those with type 2 diabetes.
If you have overweight or obesity, multi-receptor incretin drugs like Tirzepatide or Retatrutide are highly effective for significant weight loss (often >10kg) and improving blood sugar control. These benefits are even more pronounced if you do not have type 2 diabetes. While gastrointestinal side effects are common, serious safety risks are not significantly higher than placebo. Consult a healthcare provider to determine if these medications are appropriate for your specific health profile.
Supports 2025New - Macro partitioningGood
Diabetes-specific nutrition formulas (DSNFs) containing slowly-digestible carbohydrates and healthy fats significantly reduce postprandial glucose and insulin excursions compared to standard formulas or isocaloric test meals in patients with type 2 diabetes.
For Type 2 Diabetes, replacing one or two meals/snacks daily with a Diabetes-Specific Nutrition Formula (DSNF) can significantly improve blood sugar control compared to standard formulas or regular food. Look for formulas with slowly-digestible carbs and healthy fats. Dosing should be tailored to your weight and current blood sugar levels, typically 1-3 servings per day.
Supports 2022 - Energy balanceGood
Severely Energy-Restricted Diets (SERDs) utilizing meal replacements achieve approximately 10% body mass loss in people with class III obesity (BMI ≥ 40 kg/m2) when followed for 6 weeks or longer.
For individuals with severe obesity (BMI ≥ 40), a medically supervised Severely Energy-Restricted Diet using meal replacements can yield approximately 10% body weight loss if maintained for at least 6 weeks. Success requires strict adherence to the prescribed caloric intake (500-1200 kcal/day depending on the specific protocol), adequate protein supplementation, and engagement with supportive counseling to manage behavioral challenges.
Supports 2021 - MixedGood
Adopting a proinflammatory diet (Energy-Adjusted Dietary Inflammatory Index > 0) is associated with significantly increased risks of all-cause mortality, cardiovascular disease, and cancer, whereas maintaining a neutral or anti-inflammatory diet minimizes these risks.
Focus on avoiding proinflammatory foods rather than striving for a perfect anti-inflammatory diet. A neutral diet is likely sufficient to minimize your risk of heart disease and early death. Small, sustainable improvements to reduce inflammatory potential are more effective and maintainable than extreme dietary restrictions.
Supports 2023 - MixedGood
Twice-daily consumption of a multi-ingredient nutritional supplement (whey protein, creatine, calcium, vitamin D, omega-3s) reduces systemic inflammation (TNF-α, IL-6) in healthy older men, an effect enhanced by subsequent resistance and high-intensity interval training.
Older men looking to reduce chronic, low-grade inflammation should consider a specific multi-ingredient supplement containing whey protein, creatine, calcium, vitamin D, and omega-3 fatty acids, taken twice daily. This nutritional strategy, combined with a mix of resistance and high-intensity interval training, was shown to significantly lower inflammatory markers like TNF-α and IL-6 more effectively than exercise or carbohydrate control alone.
Supports 2017 - HormonalGood
Ingesting a 1:1 blend of native whey protein and micellar casein (25g) produces peak plasma leucine and essential amino acid (EAA) concentrations equivalent to whey alone, while sustaining higher EAA levels in the late postprandial period (2-6 hours) compared to whey or casein alone.
If you are consuming protein to support muscle growth, a 1:1 mix of whey and casein (25g) is an effective strategy. It gives you the fast leucine spike of whey to kickstart muscle synthesis, but keeps amino acids in your blood longer than whey alone, potentially supporting muscle building for hours after the meal. You do not need to take both separately; a pre-mixed blend achieves this.
Supports 2018 - Macro partitioningGood
A Mediterranean-style diet with high unsaturated fats and low carbohydrates reduces epicardial fat volume, whereas a standard low-calorie diet and exercise alone do not.
Adopting a Mediterranean-style diet (high in unsaturated fats, low in carbs) can reduce epicardial fat in obese HFpEF patients, even without significant weight loss. Combine this with physical activity for best results. Avoid standard low-calorie diets if they do not reduce EAT.
Supports 2023 - Energy balanceGood
Sustained weight loss of 15 kg or more through structured lifestyle interventions (such as total meal replacement diets) can induce remission of type 2 diabetes in early-stage patients.
If you have early-stage type 2 diabetes, losing a significant amount of weight (around 15 kg or 33 lbs) through a structured program can potentially put your diabetes into remission. This often involves a short period of very low-calorie intake (around 800-850 calories/day) using meal replacements, followed by a careful return to normal food. This is most effective when done under professional guidance and is most likely to work if you haven't had diabetes for very long.
Supports 2024 - HormonalGood
Pharmacological interventions with GLP-1 receptor agonists (e.g., semaglutide 2.4 mg, tirzepatide) and SGLT2 inhibitors promote weight loss and improve glycemic control, contributing to diabetes remission and reduced cardiovascular/renal risks.
If lifestyle changes alone aren't enough to control your diabetes or help you lose weight, ask your doctor about GLP-1 medications like semaglutide or tirzepatide. These are weekly injections that help you lose weight and can put type 2 diabetes into remission for many people. They also protect your heart and kidneys. They are not just 'diet pills' but powerful tools for managing the disease.
Supports 2024 - Energy balanceGood
Obesity is a root cause of type 2 diabetes, and weight loss reduces the risk of microvascular complications (retinopathy, nephropathy) and improves renal function.
Keeping your weight down is one of the most important things you can do to protect your eyes and kidneys from diabetes-related damage. Even modest weight loss can significantly lower your risk of these serious complications. This is because excess fat contributes to inflammation and stress on these organs.
Supports 2024